Award

Cravatt lauded as ‘gem of the scientific community’ for his work on activity-based protein profiling

Mark Stewart
By Mark Stewart
March 01, 2014

Benjamin Cravatt of The Scripps Research Institute in La Jolla, Calif., has been named the winner of the American Society for Biochemistry and Molecular Biology/Merck Award.
 
Cravatt, professor and chair of the chemical physiology department at Scripps, received this award based on his groundbreaking contributions to the development and application of post-genomic methods for the functional annotation of mammalian enzymes. “Cravatt pioneered the use of the now widely practiced activity-based protein profiling technology, which utilizes site-directed chemical probes to profile active enzymes in complex proteomes,” said Chaitan Khosla of Stanford University, who nominated Cravatt for the award.
 
Most proteomic technologies measure protein abundance and therefore provide only an indirect estimate of protein activity. Cravatt’s work has led to the development of a chemical strategy to profile the functional state of enzymes through the development of active site directed probes, known as activity-based protein profiling, or ABPP.
 

Benjamin Cravatt

I am tremendously honored to receive the 2014 ASBMB-Merck Award, which is a tribute to the many talented and hardworking graduate students, postdoctoral fellows and collaborators with whom I have had the pleasure of working during my career at TSRI.

—BENJAMIN CRAVATT

During his graduate work, Cravatt discovered fatty acid amide hydrolase, or FAAH, an endocannabinoid-matabolizing enzyme. ABPP revealed important roles for endocannabinoid-metabolizing enzymes in pain, inflammation and neuropsychiatric disorders. In collaboration with the pharmaceutical company Pfizer, a highly potent and selective FAAH inhibitor was developed and today is in human clinical trials. This FAAH inhibitor represents a potential new class of analgesics and a novel treatment for nervous system disorders.
 
James Wells of the University of California, San Diego, describes Cravatt as “a star at the chemistry-biology interface and a worthy recipient of this important award.”
 
Cravatt attended Stanford University, earning a B.A. in history and a B.S. in biological sciences. He then pursued a Ph.D. at The Scripps Research Institute under the mentorship of Dale Boger and Richard Lerner. At Scripps, he became an assistant professor in 1996 and rose through the ranks to become professor and chair in 2007.
 
“His love of science is overflowing and contagious. If you haven’t had the chance to hear him speak about his work, there’s nothing I’d recommend more highly,” says Daniel Herschlag of Stanford University.
 
Cravatt will receive his award at the Experimental Biology 2014 conference in San Diego. He will present his award lecture at 2:55 p.m. Tuesday, April 29, in Room 6A of the San Diego Convention Center.
Mark Stewart
Mark Stewart

Mark Stewart is a Ph.D. student in the University of Alabama at Birmingham’s cancer biology program and works in the pathology department.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Connecting chemistry with education
Jobs

Connecting chemistry with education

February 26, 2021

Meet Christiane Stachl, director of education, outreach and diversity at Center for Genetically Encoded Materials at UC Berkeley.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.

Tributes to Barbara Gordon, ASBMB executive director, on her retirement
Stroopwafels

Tributes to Barbara Gordon, ASBMB executive director, on her retirement

February 24, 2021

Society members and former staff share their appreciation and memories of Gordon who worked at the American Society for Biochemistry and Molecular Biology for almost 50 years.

Booker edits new journal; Bumpus featured in virtual museum
Member News

Booker edits new journal; Bumpus featured in virtual museum

February 22, 2021

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

Remembering Kanfer and Barry
In Memoriam

Remembering Kanfer and Barry

February 22, 2021

Julian Kanfer was one of the first researchers to study the link between amyloid ß protein and Alzheimer’s disease. Bridgette Barry focused on how the dynamic protein matrix facilitates enzyme-based catalysis.